Business
ASX set to drop as Wall Street falls on vaccine worries – Sydney Morning Herald
The ASX’s seven-session winning streak looks in danger as a pause in Johnson & Johnson’s COVID-19 trial triggered concerns on Wall Street about the timing of a …
The Dow and the S&P 500 fell on Tuesday (US time) after a four-day winning streak as a pause in Johnson & Johnson’s COVID-19 trial triggered concerns about the timing of a vaccine, although a rally in technology shares supported the Nasdaq.
Johnson & Johnson shed 2 per cent as it said it would take “a few days” to review its halted clinical trial following an unexplained illness in a study participant, possibly delaying results on one of the most closely watched efforts to contain t…
-
General11 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
Business20 hours agoWhat a rising Aussie dollar means for your ASX shares
-
Noosa News15 hours agoThree people rushed to hospital after Spring Hill unit fire
-
General21 hours agoAussies skipping dental, medical care to afford rent